Pictured: Helena Yu

Helena A. Yu, MD

Thoracic Medical Oncologist & Early Drug Development Specialist

Areas of Expertise

Conditions I Treat

  • Lung cancer

My Specialties

  • Targeted therapy
  • Clinical trials
  • Biomarker testing
View all expertise
Dr. Yu's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
English
Share

Get to Know Me

I am a board-certified medical oncologist specializing in the care of patients with lung cancer.  As a member of our multidisciplinary team that includes surgeons and radiation oncologists, I am dedicated to providing compassionate care to my patients and creating comprehensive treatment plans that are tailored to their needs and goals.

Read more

By performing molecular testing on lung cancers, we have the ability to look for specific gene mutations and personalize the treatment for each patient based on the results of these tests. I have a special interest in the use and development of newer, targeted therapies as treatment for lung cancers.

I also conduct research aimed at advancing the treatment of lung cancer so that patients can live longer and have a better quality of life.  My clinical research focuses on the treatment of patients with lung cancers that have identifiable mutations, and I oversee our clinical research program for patients with EGFR-mutant lung cancers.

What I Do at MSK

I'm a thoracic medical oncologist, which is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.

I'm an early drug development specialist, which is a scientist who tests new drugs to treat cancer. I have special training in research studies, also known as clinical trials.

  • Associate Attending Physician
Areas of Expertise

Conditions I Treat

  • Lung cancer

My Specialties

  • Targeted therapy
  • Clinical trials
  • Biomarker testing
Education & Honors

Education

  • MD, University of Michigan Medical School

Residencies

  • Internal Medicine - Hospital of the University of Pennsylvania

Fellowships

  • Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9163— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Yu sees patients at one location.

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Early Drug Development Service doctors

See all Thoracic Oncology Service doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Yu’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Helena A. Yu discloses the following relationships and financial interests:

  • AbbVie
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities
  • Black Diamond Therapeutics, Inc.
    Professional Services and Activities
  • Blueprint Medicines
    Professional Services and Activities
  • C4 Therapeutics
    Professional Services and Activities
  • Daiichi Sankyo
    Professional Services and Activities
  • Ipsen Pharma
    Professional Services and Activities
  • Janssen Pharmaceuticals, Inc.
    Professional Services and Activities
  • Taiho
    Professional Services and Activities
  • Takeda Pharmaceuticals
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: